[2]
Rees DC, Williams TN, Gladwin MT. Sickle-cell disease. Lancet 2010; 376: 2018-31.
[3]
Modell B, Darlison M. Global epidemiology of haemoglobin disorders and derived service indicators. Bull World Health Organ 2008; 86: 480-7.
[4]
Abere TA, Okoye CJ, Agoreyo FO, et al. Antisickling and toxicological evaluation of the leaves of Scoparia dulcis Linn (Scrophulariaceae). BMC Complement Altern Med 2015; 15: 414.
[6]
Piel FB, Patil AP, Rosalind E, et al. Global distribution of the sickle cell gene and geographical confirmation of the malaria hypothesis. Nat Commun 2010; 2(1): 104-12.
[7]
Nagel RL, Fabry ME, Steinberg MH. The paradox of hemoglobin SC disease. Blood Rev 2003; 17: 167-78.
[8]
Nagel RL, Lin MJ, Witkowska HE, Fabry ME, Bestak M, Hirsch RE. Compound heterozygosity for hemoglobin C and Korle-Bu: Moderate microcytic hemolytic anemia and acceleration of crystal formation. Corrected Blood 1993; 82(6): 1907-12.
[9]
Hirsch RE, Lin MJ, Nagel RL. The inhibition of hemoglobin C crystallization by hemoglobin F. J Biol Chem 1988; 263: 5936-9.
[10]
Hirsch RE, Rybicki AC, Fataliev NA, Lin MJ, Friedman JM, Nagel RL. A potential determinant of enhanced crystallization of Hbc: spectroscopic and functional evidence of an alteration in the central cavity of oxy HbC. Br J Haematol 1997; 98: 583-8.
[11]
Hirsch RE, Rybicki AC, Fataliev NA, Lin MJ, Friedman JM, Nagel RL. A potential determinant of enhanced crystallization of Hbc: Spectroscopic and functional evidence of an alteration in the central cavity of oxyHbC. Br J Haematol 1997; 98: 583-8.
[12]
Hirsch RE, Raventos-Suarez C, Olson JA, Nagel RL. Ligand state of intraerythrocytic circulating HbC crystals in homozygous CC patients. Blood 1985; 66: 775-7.
[13]
Kaul DK, Fabry ME, Nagel RL. Microvascular sites and characteristics of sickle cell adhesion to vascular endothelium in shear flow conditions: Pathophysiological implications. Proc Natl Acad Sci USA 1989; 86: 3356-60.
[14]
Fabry ME, Kaul DK, Raventos-Suarez C, Chang H, Nagel RL. SC cells have an abnormally high intracellular hemoglobin concentration: Pathophysiological consequences. J Clin Invest 1982; 70: 1315-20.
[15]
Park SY, Yokoyama T, Shibayama N, Shiro Y, Tame JR. 1.25 Å resolution crystal structures of human haemoglobin in the oxy, deoxy and carbonmonoxy forms. J Mol Biol 2006; 360: 690-701.
[16]
Berman HM, Westbrook J, Feng Z, et al. The Protein Data Bank. Nucleic Acids Res 2000; 28: 235-42.
[17]
Pettersen EF, Goddard TD, Huang CC, et al. UCSF Chimera--a visualization system for exploratory research and analy sis. J Comput Chem 2004; 25: 1605-12.
[18]
Ghatge MS, Ahmed MH, Omar AS, et al. Crystal structure of carbonmonoxy sickle hemoglobin in R-state conformation. J Struct Biol 2016; 194: 446-50.
[19]
Imaga NA. Phytomedicines and Nutraceuticals: Alternative therapeutics for sickle cell anaemia. Sci World J 2013; 2013269659
[20]
Abere TA, Egharevba CO, Chukwurah IO. Pharmacognostic evaluation and antisickling activity of the leaves of Securinega virosa Roxb. ex Willd (Euphorbiaceae). Afr J Biotechnol 2014; 13(40): 4040-5.
[21]
Morris CR. Alterations of the arginine metabolome in sickle cell disease: a growing 247 rationale for arginine therapy. Hematol Oncol Clin North Am 2014; 28(2): 301-21.
[22]
Erhabor O, Ibrahim BA, Abdulrahaman Y, et al. L arginine and no levels are diminished in Children of African Descent with Acute Vaso-Occlusive Sickle Cell Crisis in Sokoto, Nigeria. J Intern Med 2016; 2(2): 22-7.
[23]
Kato GJ, Hebbel RP, Stenberg MH, Gladwin MT. Vasculopathy in Sickle Cell Disease: Biology, Pathophysiology, Genetics, Translational Medicine and New Research Directions. Am J Hematol 2009; 84(9): 618-25.
[24]
Ameh SJ, Tarfa FD, Ebeshi BU. Traditional herbal management of Sickle Cell Anemia: Lessons from Nigeria. Anaemia 2012; 2012: 9-14.
[25]
Freire SM, Torres LM, Rogue NF, Souccar C, Lapa AJ. Analgesic activity of a triterpenes isolated from Scoparia dulcis Linn (Vassourinha). Mem Inst Oswaldo Cruz 1991; 86: 149-51.
[26]
Sulaiman CT, Gopalakrishnan VK. Radical scavenging and in-vitro Hemolytic Activity of Aqueous Extracts of Selected Acacia Species. J Appl Pharmaceutical Sci 2013; 3(03): 109-11.
[27]
Malviya S, Rawat S, Kharia A, Verma M. Medicinal attributes of Acacia nilotica Linn. - A comprehensive review on ethnopharmacological claims. Int J Pharm Life Sci 2011; 2(6): 830-7.
[28]
Li X, Wang H, Liu C, Chen R. Chemical constituents of Acacia catechu. Zhongguo Zhongyao Zazhi 2010; 35(11): 1425-7.
[29]
Sofowora A. Medicinal plants and traditional medicine in Africa. Spectrum books limited Ibadan. 2008; p. 356-374.
[30]
Sahu M, Singh V, Yadav S, Harris KK. Plant extracts with antisickling propensities: a feasible succor towards sickle cell disease management- a mini review. J Phytol 2012; 4(3): 24-9.
[31]
Agnihotri S, Wakode S, Agnihotri A. An overview on anti-inflammatory properties and chemo-profiles of plants used in traditional medicine. Indian J Nat Prod Resour 2010; 1(2): 150-67.
[32]
Okwu DE, Ukanwa N. Isolation, characterization and antibacterial activity screening of anthocyanidine glycosides from Alchornea cordifolia (Schumach. And Thonn.) Mull Arg leaves E-. J Chem 2010; 7(1): 41-8.
[33]
Mpiana PT, Tshibangu DST, Shehonde OM, Ngbolua KN. In-vitro antidrepanocytary activity (antisickle cell anaemia) of some Congolese plants. Phytomedicine 2007; 14(2-3): 192-5.
[34]
Otunola GO, Oloyede OB, Oladiji AT, Afolayan AJ. Comparative analysis of the chemical composition of three spices – Allium sativum L., Zingiber officinale Rosc. and Capsicum frutescens L. commonly consumed in Nigieria. Afr J Biotechnol 2010; 9(41): 6927-31.
[35]
Yisa J, Egila JN, Darlinton AO. Chemical composition of Annona senegalensis from Nupe land, Nigeria. Afr J Biotechnol 2010; 9(26): 4106-9.
[36]
Fadeyi OE, Fabiyi OA, Olatunji GA, Ahmed A. Comparative in Vitro and Screenhouse Response of Abelmoschus esculentus Infected with Meloidogyne Incognita to Anacardium. University of Mauritius Research Journal 2016; p. 22.
[37]
Mpiana PT, Ngbolua KTNN, Bokota MT, et al. In vitro effects of anthocyanin extracts from Justicia secunda Vahl on the solubility of Haeemoglobin S and membrane stability of sickle erythrocytes. Blood Transfus 2010; 8(4): 248-54.
[38]
Pal D, Mishra P, Sachan N, Ghosh AK. Biological activities and medicinal properties of Cajanus cajan (L) Millsp. J Adv Pharm Technol Res 2011; 2(4): 207-14.
[39]
Zu YG, Liu XL, Fu YJ, et al. Chemical composition of the SPE-CO extracts from Cajanus cajan (L.) Huth and their antimicrobial activity in vitro and in vivo. Phytomed 2010; 17: 1095-101.
[40]
Foster S. Green Tea (Camellia sinensis). Alternative Medicine Review Monographs Thorne Inc 2002; 200-204.
[41]
Ohnishi ST, Ohnishi T, Ogunmola GB. Green tea extract and aged garlic extract inhibit anion transport and sickle cell dehydration in-vitro. Blood Cells Mol Dis 2001; 27: 148-57.
[42]
Afolabi IS, Osikoya IO, Fajimi OD, Usoroh PI. zeylanica and Uvaria. Afr J Biotechnol 2012; 9(53): 9032-6.
[43]
Oduola T, Adeniyi FAA, Ogunyemi EO, Bello IS, Idowu TO. Antisickling agent in an extract of unripe pawpaw (Csarica papaya). Afr J Biotechnol 2006; 5(20): 1947-9.
[44]
Elumalai A, Mathangi N, Didala A, Kasarla R, Venkatesh Y. A Review on Ceiba pentandra and its medicinal features. Asian J Pharm Technol 2012; 2(3): 83-6.
[45]
Soladoye MO, Chukwuma EC. Phytochemical analysis of the stem and root of Cissus populnea (Vitaceae) – an important medicinal plant in Central Nigeria. Phytol Balcanica 2012; 18(2): 149-53.
[46]
Simeone EI, Tufon EN, Victor ON, Noel NN. Antisickling potential of the ethanol seed extracts of Vigna unguiculata and Vigna subterranean. Int J Biochem Biotechnol 2012; 1(9): 226-9.
[47]
Moody JO, Ojo O, Omotade OO, Adeyemo AA, Olusese PE, Ogundipe A. Anti-sickling potential of a Nigerian herbal formular and the major plant component Cissus populnea L. CPK. Phytother Res 2003; 10: 1137-76. a
[48]
Ejele AE, Akpan IO, Ogukwe CE, Onyeocha VO, Ukiwe LN. Bioassay-guided isolation and partial characterization of an antisickling compound from Enantia chlorantha. Intern Res J Biochem Bioinform 2012; 2(7): 149-54.
[49]
Singh J, Baghotia A, Goel SP. Eugenia caryophyllata Thunberg (Family Myrtaceae): A Review. IJRPBS 2012; 3(4): 1469-75.
[50]
Chaieb K, Hajlaoui H, Zmantar T, et al. The chemical composition and biological activity of clove essential oil, Eugenia caryophyllata (Syzigium aromaticum L. Myrtaceae): A short review. Phytother Res 2007; 21(6): 501-6.
[51]
Wambebe C, Khamofu H, Momoh JA, et al. Double-blind, placebo-controlled, randomised cross-over clinical trial of NIPRISAN in patients with sickle cell disorder. Phytomedicine 2001; 8(4): 252-61.
[52]
Mpiana PT, Mudogo V, Kabangu YF. Antisickling activity and thermostability of anthocyanins extract from a congolese plant, Hymenocardia acida Tul. (Hymenocardiaceae). Int J Pharmacol 2009; 5: 65-70.
[53]
Correa GM, Alcântara AFC. Chemical constituents and biological activities of species of Justicia - a review. Braz J Pharmacogn 2012; 22(1): 220-38.
[54]
Tshilanda DD, Mpiana PT, Onyamboko DNV, et al. Antisickling activity of butyl stearate isolated from Ocimum basilicum (Lamiaceae). Asian Pac J Trop Biomed 2014; 4(5): 393-8.
[55]
Gbadamosi IT, Adeyemi SB, Adeyemi AA, Moody JO. In vitro antisickling activities of two indigenous plant recipes in Ibadan, Nigeria. Int J Phytochem 2013; 4(2): 205-11.
[56]
Ohnishi ST, Ohnishi T, Ogunmola GB. Green tea extract and aged -garlic extract inhibit anion transport and sickle cell dehydration in vitro. Blood Cells Molecules, and Diseases 2001; 27: 148-57.
[57]
Ekanem AP, Udoh FV, Oku EE. Effects of ethanol extract of Piper guineense seeds (Schum. and Thonn) on the conception of mice (Mus musculus). Afr J Pharm Pharmacol 2010; 4(6): 362-7.
[58]
Tzeng SH, Ko WC, Ko FN, Teng CM. Inhibition of platelet aggregation by some flavonoids. Thromb Res 1991; 64: 91-100.
[59]
Kokkalou E, Souleles C. Flavonoid constituents of Pelergonium xasperum Enrh. Ex Willd. Geraniaceae. Plantes Med Phytother 1988; 22: 247-53.
[60]
Arukwe U, Amadi BA, Duru MKC, et al. Chemical composition of Persea americana leaf, fruit and seed. IJRRAS 2012; 11(2): 346-9.
[61]
Owolabi MA, Coker HAB, Jaja SI. Bioactivity of the phytoconstituents of the leaves of Persea Americana. J Med Plants Res 2010; 4(12): 1130-5.
[62]
Kubec R, Kim S, Musah RA. S-Substituted cysteine derivatives and thiosulfinate formation in Petiveria alliacea-Part II. Phytochemistry 2002; 61: 675-80.
[63]
Kubec R, Musah RA. Cysteine sulfoxide derivatives in Petiveria alliacea. Phytochemistry 2001; 58: 981-5.
[64]
Gosmann G, Gattuso S, Gattuso M, et al. Botanical (morphological, micrographic), chemical and pharmacological characteristics of Pfaffia species (Amaranthaceae) native to South Brazil. Braz J Pharm Sci 2003; 39(2): 142-7.
[65]
Mazzanti G, Braghiroli L. Analgesic, anti-inflammatory action of Pfaffia paniculata (Martius) Kuntze. Phytother Res 1994; 8: 413-6.
[66]
Adejumo COE, Kolapo AL, Roleola OP, Kasim LS. In vitro antisickling activities and phytochemical evaluation of Plumbago. Altern Med 2010; 2(3): 282-301.
[67]
Vijayakumar R, Senthilvelan M, Ravindran R, Devi RS. Plumbago zeylanica action on blood coagulation profile with and without blood volume reduction. Vascul Pharmacol 2006; 45(2): 86-90.
[68]
Iyamu EW, Turner EA, Asakura T. Niprisan (Nix-0699) improves the survival rates of transgenic sickle cell mice under acute severe hypoxic conditions. Br J Haematol 2003; 122(6): 1001-8.
[69]
Iyamu EW, Turner EA, Asakura T. In vitro effects of Niprisan (Nix 0699). A natural occurring potent antisickling agent. Br J Haematol 2002; 118(1): 337-43.
[70]
Anowi CF, Umeokoli BO, Onyegbule AF, Okonkwo C, Chibeze I. Analgesic, phytochemical and acute toxicity evaluation of the methanol extract of the leaves of Pterocarpus santalinoides- Family Fabacea. IJPSR 2012; 3(7): 2018-23.
[71]
Okpuzor J, Adebesin O, Ogbunugafor H, Amadi I. The potential of medicinal plants in sickle cell disease control: A review. Int J Biomed Health Sci 2008; 4(2): 47-55.
[72]
Abugri DA, Tiimob BJ, Apalangya VA, Pritchett G, McElhenney WH. Bioactive and nutritive compounds in Sorghum bicolor (Guinea corn) red leaves and their health implication. Food Chem 2013; 138(1): 718-23.
[73]
Mpiana PT, Ngbolua KN, Mudogo V, et al. Anti Sickle Erythrocytes Haemolysis Properties and Inhibitory Effect of Anthocyanins Extracts of Trema orientalis (Ulmaceae) on the Aggregation of Human Deoxyhemoglobin S in vitro. J Med Sci 2011; 11: 129-37.
[74]
Elekwa I, Monanu MO, Anosike EO. In vitro effects of aqueous extracts of Zanthxylum macrophyla roots on adenosine triphosphatases from human erythrocytes of different genotypes. Biokemistri 2005; 17(1): 19-25.
[75]
Adesina SK. The Nigerian Xanthoxylum; Chemical and Biological Values. Afr J Trad Compl Alternat Med 2005; 2(3): 282-301.
[76]
Ameh SJ, Obodozie OO, Chindo BA, Babalola PC, Gamaniel KS. Herbal clinical trials-historical development and application in the 21st Century. Pharmacologia 2012; 3: 121-31.
[77]
Meena S, Varsha S, Somnath Y, Harris KK. Plant extracts with antisickling propensities: A feasible succour towards sickle cell disease management- a mini review. J Phytol 2012; 4(3): 24-9.
[78]
Ameh SJ, Tarfa FD, Ebeshi BU. Traditional Herbal Management of Sickle Cell Anemia: Lessons from Nigeria. Anemia 2012; 2012607436
[79]
Amidon GL, Lennernas H, Shah VP, Crison JR. A theoretical basis for a biopharmaceutic drug classification: The correlation of in vitro drug product dissolution and in vivo bioavailability. Pharm Res 1995; 12: 413-20.
[80]
Gupta S, Kesarla R, Omri A. Formulation Strategies to Improve the Bioavailability of Poorly Absorbed Drugs with Special Emphasis on Self-Emulsifying Systems. ISRN Pharm 2013; 2013848043
[81]
Ang HH. Analysis of lead content in herbal preparations in Malaysia. Hum Exp Toxicol 2003; 22: 445-51.
[82]
Ang HH, Lee EL, Cheang HS. Determination of mercury by cold vapor atomic absorption spectrophotometer in tongkat ali preparations obtained in Malaysia. Int J Toxicol 2004; 23: 65-71.
[83]
Parab S, Kulkarni RA, Thatte U. Heavy metals in herbal medicines. Indian J Gastroenterol 2003; 22: 111-2.
[84]
Busari AA, Mufutau MA. High prevalence of complementary and alternative medicine use among patients with sickle cell disease in a tertiary hospital in Lagos, South West, Nigeria. BMC Complement Altern Med 2017; 17: 299.
[85]
Oshikoya KA, Senbanjo IO, Njokanma OF, Soipe A. Use of complementary and alternative medicines for children with chronic health conditions in Lagos. BMC Complement 2008; 8: 66.
[86]
Phua DH, Zosel A, Heard K. Dietary supplements and herbal medicine toxicities-when to anticipate them and how to manage them. Int J Emerg Med 2009; 2(2): 69-76.
[87]
Adeyeye M, Gbadero D, Farayola L, Olalere N. Evaluation of an Undocumented Polyherbal (Faradin®) Used for the Treatment of Sickle Cell Disease in West Africa. Part I: Phytochemistry and Ex-vivo Anti-sickling Study. BJPR 2017; 17(1): 1-14.
[88]
Wanwimolruk S, Prachayasittikul V. Cytochrome P450 mediated herbal drug interactions (Part 1). EXCLI J 2014; 13: 347-91.
[89]
Hermann R, von Richter O. Clinical evidence of herbal drugs as perpetrators of pharmacokinetic drug interactions. Planta Med 2012; 78: 1458-77.
[90]
Verma A, Gupta AK, Kumar A, Khan PK. Cytogenetic toxicity of Aloe vera (a medicinal plant). Drug Chem Toxicol 2012; 35(1): 32-25.
[91]
Wang BQ. Salvia miltiorrhiza: Chemical and pharmacological review of a medicinal plant. J Med Plants Res 2010; 4(25): 2813-20.
[92]
Barbosa-Ferreira M, Dagli ML, Maiorka PC, Gorniak SL. Sub-acute intoxication by Senna occidentalis seeds in rats. Food Chem Toxicol 2005; 43(4): 497-503.
[93]
Lanski SL, Greenwald M, Perkins A, Simon HK. Herbal therapy use in a paediatric emergency department population: expect the unexpected. Paediatrics 2003; 111: 981-5.
[94]
Awang DV, Fugh-Berman A. Herbal interactions with cardiovascular drugs. J Cardiovasc Nurs 2002; 16(4): 64-70.
[95]
Fugh-Berman A. Herb-drug interactions. Lancet 2000; 355: 134-8.
[96]
Izzo AA, Ernst E. Interactions between herbal medicines and prescribed drugs: a systematic review. Drugs 2001; 61: 2163-75.
[97]
Akinleye MO, Amaeze OU, Opeodu OT, Okubanjo OO. Effect of Ciklavitβ - a Nigerian Poly-herbal Formulation on the Dissolution Profile of Proguanil Tablets: Potential for Herb-drug Interaction. BJPR 2016; 12(6): 1-9.
[98]
Thorne S, Paterson B, Russell C, Schultz A. Complementary/alternative medicine in chronic illness as informed self-care decision making. Int J Nurs Stud 2002; 39(7): 671-83.
[99]
Nayyar GM, Attaran A, Clark JP, et al. Responding to the pandemic of falsified medicines. Am J Trop Med Hyg 2015; 92(6)(Suppl.): 113-8.
[100]
Falodun A. Herbal Medicine in Africa-Distribution, Standardization and Prospects. Res J Phytochem 2010; 4: 154-61.
[101]
Falodun A, Qadir MI, Choudhary MI. Isolation and characterization of xanthine oxidase inhibitory constituents of Pyrenacantha staudtii. Yao Xue Xue Bao 2009; 44: 390-4.
[102]
Idoko OT, Kochhar S, Agbenyega TE, Ogutu B, Ota MO. Impact, challenges, and future projections of vaccine trials in Africa. Am J Trop Med Hyg 2013; 88(3): 414-9.
[103]
Puppalwar G, Mourya M, Kadhe G, Mane A. Conducting clinical trials in emerging markets of sub-Saharan Africa: Review of guidelines and resources for foreign sponsors. Open Access J Clin Trials 2015; 7: 23-34.
[104]
Ndomondo-Sigonda M, Miot J, Naidoo S, Dodoo A, Kaale E. Medicines Regulation in Africa: Current State and Opportunities. Pharmaceut Med 2017; 31: 383-97.
[105]
Chikowe I, Osei-Safo D, Harrison JJ, et al. Post-marketing surveillance of anti-malarial medicines used in Malawi. Malar J 2015; 14: 127.
[106]
Njeri M, Ouma C, Kibiego P, et al. Post market survey of antiretroviral medicines in Kenya. NASCOP, Nairobi. 2012.
[107]
WHO. Survey of the quality of selected antimalarial medicines circulating in six countries of sub-Saharan Africa. WHO Press, Geneva. 2011.
[108]
Ray PD, Yosim A, Fry RC. Incorporating epigenetic data into the risk assessment process for the toxic metals arsenic, cadmium, chromium, lead, and mercury: Strategies and challenges. Frontiers in Genetics 2014; 5: 201.
[109]
Lettre G, Sankaran VJ, Bezerra MAC, et al. DNA polymorphisms at the BCL11A, HBS1L-MYB, and -globin loci associate with fetal hemoglobin levels and pain crises in sickle cell disease. Proc Natl Acad Sci USA 2008; 105(33): 11869-74.
[110]
Sebastiani P, Solovieffi N, Hartley SW, et al. Genetic modifiers of the severity of sickle cell anemia identified through a genome-wide association study. Am J Hematol 2010; 85(1): 29-35.
[111]
Alsultan A, Ngo DA, Farrell JJ, et al. A functional promoter polymorphism of the δ-globin gene is a specific marker of the Arab-Indian haplotype. Amer Jnl Hematol 2012; 87: 824-6.
[112]
Hammer C, Begemann M, McLaren PJ, et al. Amino Acid Variation in HLA Class II Proteins Is a Major Determinant of Humoral Response to Common Viruses. Am J Hum Genet 2015; 97(5): 738-43.
[113]
Bauer DE, Kamran SC, Lessard S, et al. An erythroid enhancer of BCL11A subject to genetic variation determines fetal hemoglobin level. Science 2013; 342: 253-.
[114]
Guillaume L, Vijay GS, Bezerra MAC, et al. DNA polymorphisms at the BCL11A, HBS1L-MYB, and_-globin loci associate with fetal hemoglobin levels and pain crises in sickle cell disease. Proc Natl Acad Sci USA 2008; 105(33): 11869-74.
[115]
Bogdanović O, Veenstra GJC. DNA methylation and methyl-CpG binding proteins: Developmental requirements and function. Chromosoma 2009; 118(5): 549-65.
[116]
Umesh K, Ujjawal S, Garima R. Reversal of hypermethylation and reactivation of glutathione S-transferase pi 1 gene by curcumin in breast cancer cell line. Tumour Biol 2017; 39(2)1010428317692258
[117]
Khor TO, Huang Y, Wu TY. Pharmacodynamics of curcumin as DNA hypomethylation agent in restoring the expression of Nrf2 via promoter CpGs demethylation. Biochem Pharmacol 2011; 82: 1073-8.
[118]
Axelsson AS, Tubbs E, Mecham B, et al. Sulforaphane reduces hepatic glucose production and improves glucose control in patients with type 2 diabetes. Sci Transl Med 2017; 9(394): 4477.
[119]
Alli LA, Okoh MP. Phyto-Medicine in Gene(s) Targeting Future Direction for Sickle Cell Disease Management. Hereditary Genet 2016; 5: 2.
[120]
Arango D, Morohashi K, Yilmaz A, et al. Molecular basis for the action of a dietary flavonoid revealed by the comprehensive identification of apigenin human targets. Proc Natl Acad Sci USA 2013; 110(24): E2153-62.
[121]
Busch C, Burkard M, Leischner C, Lauer UM, Frank J, Venturelli S. Epigenetic activities of flavonoids in the prevention and treatment of cancer. Clin Epigenetics 2015; 7: 64.
[122]
Gilbert ER, Liu D. Flavonoids influence epigenetic-modifying enzyme activity:structure - function relationships and the therapeutic potential for cancer. Curr Med Chem 2010; 17(17): 1756-68.
[123]
Delcuve GP, Khan DH, Davie JR. Roles of histone deacetylases in epigenetic regulation: Emerging paradigms from studies with inhibitors. Clin Epigenetics 2012; 4(1): 5.
[124]
Ginzburg Y, Rivella S. beta-thalassemia: A model for elucidating the dynamic regulation of ineffective erythropoiesis and iron metabolism. Blood 2011; 118: 4321-30.
[125]
Bassett SA, Barnett MPG. The Role of Dietary Histone Deacetylases (HDACs) Inhibitors in Health and Disease. Nutrients 2014; 6(10): 4273-301.
[126]
Kinnersley B, Labussiere M, Holroyd A, et al. Genome-wide association study identifies multiple susceptibility loci for glioma. Nat Commun 2015; 6: Article number: 8559.
[127]
Sankaran VG. Targeted therapeutic strategies for fetal hemoglobin induction. Hematology (Am Soc Hematol Educ Program) 2011; 2011: 459-65.
[128]
Sankaran VG, Menne TF, Xu J, et al. Human fetal hemoglobin expression is regulated by the developmental stage-specific repressor BCL11A. Science 2008; 322: 1839-42.
Download PDF Flyer